文献速递眼底病与葡萄膜炎

评估电子视网膜植入物Alpha AMS在终末期视网膜色素变性盲患者中恢复视力的作用

Assessment of the Electronic Retinal Implant Alpha AMS in Restoring Vision to Blind Patients with End-Stage Retinitis Pigmentosa.
PubMed 文献 · Ophthalmology · 2017-10-27

这项前瞻性单臂干预临床试验将Retina Implant Alpha AMS植入6例终末期视网膜色素变性患者视力较差眼,在植入物开启与关闭条件下进行自身对照。结果显示5例患者获得光定位、光栅检测和桌面物体识别等视力改善,1例因植入物损伤及植入位置不当功能不佳;报告结膜糜烂、视网膜脱离和植入物损伤等不良事件,植入物持续功能最长24个月。

要点

  • 6例终末期视网膜色素变性患者植入Alpha AMS后,全部实现光感知和时间分辨率。
  • 5例患者植入物开启时获得光栅检测(0.1至3.33周期/度)和桌面物体定位能力,植入物关闭时未获得。
  • 报告2例结膜糜烂、1例颞下黄斑在位视网膜脱离和2例术中植入物意外损伤,均经修复。

核心结论

  • Alpha AMS视网膜下植入物改善了6例参与者中5例的视觉表现,并已显示持续功能长达24个月。
  • 尽管植入手术仍具挑战性,OCT显微镜引导等新进展为手术技术增加了改进。

研究设计与样本

  • 前瞻性、单臂、研究者发起的干预性临床试验,采用参与者内对照,比较植入眼植入物开启与关闭时的残余视力。
  • 植入物植入6例终末期视网膜色素变性且无有用光感知的患者视力较差眼;入选标准包括既往正常视力≥12年且无显著眼部或全身合并症。

主要发现

  • 全部6例参与者成功植入;植入物开启时全部实现光感知和时间分辨率。
  • 除1例(P4)外,其余参与者植入物开启时实现光定位;P4因术中植入物损伤合并植入位置不当导致芯片功能不佳。
  • 其余5例参与者记录到植入物开启时正确光栅检测,范围为0.1至3.33周期/度(单次 occasion),植入物关闭时处于随机水平。
  • 除1例(P4)外,其余参与者植入物开启时部分恢复定位高对比度桌面物体的能力,而这些物体在植入物关闭时无法看到。
  • 报告2例结膜糜烂和1例颞下黄斑在位视网膜脱离,均成功修复;另报告2例术中植入物意外损伤(P3和P4)。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: To report the initial efficacy results of the Retina Implant Alpha AMS (Retina Implant AG, Reutlingen, Germany) for partial restoration of vision in end-stage retinitis pigmentosa (RP). DESIGN: Prospective, single-arm, investigator-sponsored interventional clinical trial. Within-participant control comprising residual vision with the retinal implant switched ON versus OFF in the implanted eye. PARTICIPANTS: The Retina Implant Alpha AMS was implanted into the worse-seeing eye of 6 participants with end-stage RP and no useful perception of light vision. Eligibility criteria included previous normal vision for ≥12 years and no significant ocular or systemic comorbidity. METHODS: Vision assessments were scheduled at 1, 2, 3, 6, 9, and 12 months postimplantation. They comprised tabletop object recognition tasks, a self-assessment mobility questionnaire, and screen-based tests including Basic Light and Motion (BaLM), grating acuity, and greyscale contrast discrimination. A full-field stimulus test (FST) was also performed. MAIN OUTCOME MEASURES: Improvement in activities of daily living, recognition tasks, and assessments of light perception with the implant ON compared with OFF. RESULTS: All 6 participants underwent successful implantation. Light perception and temporal resolution with the implant ON were achieved in all participants. Light localization was achieved with the implant ON in all but 1 participant (P4) in whom the chip was not functioning optimally because of a combination of iatrogenic intraoperative implant damage and incorrect implantation. Implant ON correct grating detections (which were at chance level with implant OFF) were recorded in the other 5 participants, ranging from 0.1 to 3.33 cycles/degree on 1 occasion. The ability to locate high-contrast tabletop objects not seen with the implant OFF was partially restored with the implant ON in all but 1 participant (P4). There were 2 incidents of conjunctival erosion and 1 inferotemporal macula-on retinal detachment, which were successfully repaired, and 2 incidents of inadvertent damage to the implant during surgery (P3 and P4). CONCLUSIONS: The Alpha AMS subretinal implant improved visual performance in 5 of 6 participants and has exhibited ongoing function for up to 24 months. Although implantation surgery remains challenging, new developments such as OCT microscope guidance added refinements to the surgical technique.

来源:Ophthalmology,查看原文。版权归原作者所有。

引用

  1. Edwards TL, Cottriall CL, Xue K, et al. Assessment of the Electronic Retinal Implant Alpha AMS in Restoring Vision to Blind Patients with End-Stage Retinitis Pigmentosa. Ophthalmology. 2017. PMID: 29110946. doi:10.1016/j.ophtha.2017.09.019

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。